S&P Pharma Dose
by S&P Global Ratings
September 22, 2020 1:00 am
Hosted by Arthur Wong, Ji Liu, and other editors and analysts, the S&P Pharma Dose podcast from S&P Global Ratings discusses all things pharma from a credit perspective.
Recent Episodes
What Bausch RemainCo’s Credit Quality Post-Spinoff Could Look Like
4 years agoRegeneron Pharmaceuticals: Steady Growth vs. Heavy Product Concentration
4 years agoEpisode 34: More Color on PPD’s Rating After IPO
5 years agoEpisode 33: Pharmacy Benefit Manager Industry In 2020: Less Regulatory Overhang, Expect More Consolidations
5 years agoEpisode 32: Pfizer Finds Home For Upjohn, Though Lessened Diversity Results In Lower Rating
5 years agoEpisode 31: Thoughts On Pharma’s Washington Grilling
6 years agoEpisode 30: Rebates And Pharma Supply Chain
6 years agoEpisode 29: Just When You Thought It Was Safe to Go Back In the Water - Amazon Buys PillPack
6 years agoEpisode 28: President Trump's American Patient First Speech - Placebo?
7 years agoEpisode 27: Bezos, Buffett, and Dimon - Welcome to the Healthcare Party
7 years ago